Debt Financing - New Haven Pharmaceuticals - Aug 17, 2016 Funding Round Profile - Cointime

Bitcoin $99,123.51 +4.32%
Ethereum $3,358.75 +8.84%
BNB $635.27 +5.50%
Optimism $2.03 +23.70%
Arbitrum $0.77 +14.53%
Solana $262.56 +11.81%
Polygon $0.46 +7.81%
Cosmos $6.56 +7.75%
Avalanche $36.62 +10.81%

Bitcoin $99,123.51 +4.32%
Ethereum $3,358.75 +8.84%
BNB $635.27 +5.50%
Optimism $2.03 +23.70%
Arbitrum $0.77 +14.53%
Solana $262.56 +11.81%
Polygon $0.46 +7.81%
Cosmos $6.56 +7.75%
Avalanche $36.62 +10.81%

New Haven Pharmaceuticals

company

Funding Round

Debt Financing

Money Raised

$ 602.22K

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Advantage Capital	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Dec 31, 2013	Debt Financing	0	Advantage Capital	Detail
Oct 29, 2012	Series A	$ 6.49M	Advantage Capital,EJ Funds	Detail
Sep 30, 2012	Series Unknown	0	Advantage Capital	Detail
Oct 7, 2015	Debt Financing	$ 6.30M	Horizon Technology Finance	Detail
Oct 23, 2014	Series B	$ 11.78M	EJ Funds	Detail